Hypothyroidism Clinical Trial
Official title:
Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients
Verified date | September 2023 |
Source | Children's Mercy Hospital Kansas City |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Children with levothyroxine (T21) have developmental delay and other functional gastrointestinal (GI) issues that may negatively affect L-T4 tolerability and absorption. For an age group unable to swallow tablets whole by mouth, tablets must be crushed and suspended in water, breast milk or formula for administration in order to treat children with hypothyroidism. For this age group, ease of administration may have a significant impact on compliance and ability to remain euthyroid. We propose that Tirosint-SOL® will be more favorably received due to ease of administration, improved tolerability and palatability, therefore leading to improved adherence when compared to L-T4 tablets.
Status | Terminated |
Enrollment | 6 |
Est. completion date | November 1, 2021 |
Est. primary completion date | November 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Months to 4 Years |
Eligibility | Inclusion Criteria: - Trisomy 21 children age 2 months to less than 5 years of age - Prior confirmed diagnosis of congenital or acquired hypothyroidism Exclusion Criteria: - Gestational age = 35 weeks, concomitant anticonvulsant medications, history of nonadherence with medication or medical visit schedule - Subjects must be able to take oral medication, no G-tube or parental fed subjects |
Country | Name | City | State |
---|---|---|---|
United States | Children's Mercy Hospital | Kansas City | Missouri |
Lead Sponsor | Collaborator |
---|---|
Children's Mercy Hospital Kansas City |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tolerability as Assessed by the CareCAT Tool | Utilize medication tolerability questionnaire, Care Children's Acceptance Tool (CAT), to understand parental perceptions of liquid stable L-T4. | 4 months | |
Secondary | Adherence to Taking Study Medication | Evaluate differences in compliance with liquid stable L-T4 compared to L-T4 tablet. Evaluated in percentage of days compliant. | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05975866 -
The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato
|
N/A | |
Not yet recruiting |
NCT05334771 -
Early Detection of Endolymphatic Hydrops in Hypothyroid Patients
|
||
Withdrawn |
NCT01707056 -
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
|
N/A | |
Completed |
NCT00094237 -
Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke
|
N/A | |
Recruiting |
NCT06015620 -
Comorbidities Resolution After MGB Surgery and Change in Body Composition
|
||
Completed |
NCT03612908 -
TSHβX1 and D2 THR92ALA in Pregnancy
|
||
Completed |
NCT04782856 -
Energy Metabolism in Thyroidectomized Patients
|
Phase 2 | |
Completed |
NCT01921452 -
Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit
|
Phase 4 | |
Completed |
NCT01197183 -
Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France
|
N/A | |
Recruiting |
NCT05247476 -
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
|
Phase 4 | |
Recruiting |
NCT03754621 -
Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
|
||
Completed |
NCT02959827 -
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
|
||
Completed |
NCT04124705 -
A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
|
Phase 2 | |
Withdrawn |
NCT02577367 -
Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
|
Phase 4 | |
Completed |
NCT04098991 -
Improving White Matter Integrity With Thyroid Hormone
|
||
Not yet recruiting |
NCT03257566 -
Hypothyroidism in Patients With Type 1 Diabetes
|
N/A | |
Terminated |
NCT02567877 -
Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
|
||
Completed |
NCT02280330 -
Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months
|
Phase 4 | |
Completed |
NCT00403390 -
Generic vs. Name-Brand Levothyroxine
|
N/A | |
Not yet recruiting |
NCT06096454 -
Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance
|
Phase 4 |